Condition
Arthritis Hip
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed3
Recruiting2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05760534Phase 4Completed
Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia
NCT06775704RecruitingPrimary
Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System
NCT05788016Not ApplicableRecruiting
Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
NCT05845177Completed
Persistent Pain After Hip Replacement
NCT04479462Unknown
The Establishment of Total Joint Arthroplasty Registry Database
NCT01345123Not ApplicableCompleted
Supporting Decision Making for Musculoskeletal Preference-Sensitive Care
Showing all 6 trials